Hormonal regulation of glycogen synthase and phosphorylase activities were studied in human polymorphonuclear leukocytes. Polymorphonuclear leukocytes from normal subjects were incubated with glucose, insulin, ΑΖ,-isoproterenol and L-thyroxine, either independently or in different combinations, and changes of the enzyme activity ratios of glycogen synthase (active form (I) / total activity (T)) and glycogen phosphorylase (active form (a) / total activity (T)) were assessed.
Introduction
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* A -r ι *· i_ L glycogen synthase activity were observed in hyperthyof saturating concentrations of glucoses-phosphate.
., / * j -^ r Ii. · r r j ,1\ τ,, p A . . 4 4 . /T/r~ £ .j ~ , roid rats treated with L-thyroxme for forty days (3). The enzyme activity ratio (I/T) thus provides a useful In the present study, to investigate the hormonal regulation of these enzyme activities, we carried out the in vitro incubation of human polymorphonuclear leukocytes with glucose, insulin, Z),L-isoproterenol and L-thyroxine, since polymorphonuclear leukocytes are easily available from human tissues and contain a sufficient amount of glycogen (12) .
Materials and Methods

Materials UDP-[
14 C]glucose (specific activity 11.9 GBq/mmol) was purchased from New England Nuclear and oc-£>-[U-
I4
C]glucose-lphosphate (specific activity 11.6 GBq/mmol) was from Amersham International pic. UDP-glucose, glucose-1-phosphate, glucose-6-phosphate, porcine insulin and AL-isoproterenol were from Sigma. L-Thyroxine was a generous gift from Takeda Chemical Industry. Ficoll-Hypaque was from Pharmacia. All other reagents were of the highest purity commercially available.
Separation of polymorphonuclear leukocytes
Twenty ml of heparinized venous blood was collected from non-diabetic subjects and polymorphonuclear leukocytes were isolated by dextran sedimentation of the erythrocytes and differential centrifugation of the polymorphonuclear leukocytes using Ficoll-Hypaque. Contaminating erythrocytes were haemolysed by 8.7 g/l NH 4 C1, pH 7.4. Polymorphonuclear leukocytes were suspended at a concentration of 20 χ 10 9 /1 in a buffer consisting of 50 mmol/1 Tris-HCl and 5 mmol/1 EDTA, pH 7.8 (12, 13) .
Glycogen synthase assay
In the preliminary study, to assess the effect of L-thyroxine on glycogen synthase activity, we incubated polymorphonuclear leukocytes with various concentrations of L-thyroxine for the indicated times as shown in figure 1 . Apparently, the maximal effect of L-thyroxine was obtained at the concentration of 3.2 μιηοΐ/ΐ (A) and at the time of 2 min (B).
The effect of glucose, insulin and Z>,L-isoproterenol on the glycogen synthase activity was examined as described by Juki et al. (7) with slight modifications. Briefly, suspensions of polymorphonuclear leukocytes were preincubated in the buffer for 5 min and then incubated with 30 mmol/1 glucose and/or 1.62 nmol/1 insulin for 4 min, and/or 1 μπιοΙ/1 Z),L-isoproterenol for l min and/or 3.2 μιηοΐ/ΐ L-thyroxine for 2 min individually and together. All incubations were done at 37 °C. The suspensions were then ultrasonically disrupted with 100 mmol/1 NaF. This crude homogenate was then centrifuged at 10000 min~J for 5 min at 4 °C using a microfuge and the supernatant was assayed with a mixture containing 6.7 mmol/1 UDP-[ 
Statistical analysis
Statistical differences between the groups were established with Studenfs t test. Results are presented as mean ± SD.
Glycogen phosphorylase assay
Polymorphonuclear leukocytes were incubated with several reâ gents under the same conditions described above. Incubations were stopped by the addition of MES buffer (10 mmol/1 MES (morpholinoethanesulphonic acid), 50 mmol/I NaF, 25 mmol/1 -glycerophosphate, 10 mmol/1 EDTA containing 0.1 mg digitonin, pH 6.1). Glycogen phosphorylase activity was measured
Results
Changes of glycogen synthase and phosphorylase activity ratios are summarized in table 1 and 2, respectively. The effect of glucose and insulin on the glycogen synthase activity ratio is graphed in figure 2.
Tab. 1. Changes of glycogen synthase activity (fraction of I) after incubation with various reagents.
Effectors
Before After Significance The proportions of glycogen synthase I were 0.322 ± 0.108 and 0.335 + 0.104, before and after treatment with glucose, respectively. By treatment with insulin, the values of synthase Ϊ were changed from 0.290 ± 0.149 to 0.282 ± 0.184. From these data, neither glucose nor insulin had an apparent effect on the enzyme activity ratio. When polymorphonuclear leukocytes were incubated with both glucose and insulin, the values for synthase I increased from 0.362 ± 0.100 to 0.531 ± 0.129 (p < 0.02). Figure 3 shows the changes in the proportion of glyeogen synthase I Figure 5 shows the effect of glucose and insulin on the glycogen phosphorylase activity ratio. Insulin had no effect on the glycogen phosphorylase activity ratio, but glucose apparently decreased the enzyme activity ratio. The values for phosphorylase a decreased from 0.472 ± 0.044 to 0.343 ± 0.026 (p < 0.005). Glucose plus insulin showed no further changes of the enzyme activity ratio (data not shown). Z),L-isoproterenol and L-thyroxine increased the enzyme activity ratio ( fig.  6 ). By treatment with D,L-isoproterenol, the values for phosphorylase a increased from 0.442 ± 0.051 to 0.606 ± 0.088 (p < 0.02). With L-thyroxine treatment, the values for phosphorylase a increased from 0.434 ± 0.065 to 0.553 + 0.083 (p < 0.02). When polymorphonuclear leukocytes were incubated with glucose and Z),L-isoproterenol at the same time, the decrease observed in the presence of glucose was abolished, and the values for phosphorylase a increased from 0.378 ± 0.024 to 0.504 ± 0.019 (Fig. 7 , p < 0.005). Incubation with glucose and L-thyroxine simultaneously produced similar results, and the values for phosphorylase a increased from 0.388 ± 0.014 to 0.493 ± 0.019 ( fig. 7 , p < 0.02).
Discussion
Impaired glucose tolerance is frequently observed in hyperthyroid patients (14) (15) (16) . Glucose intolerance has been ascribed to rapid gastric emptying and absorption of nutrients as well as increased splanchnic gluconeogenic precursors and glycogenolytic turnover rates (16 -18) , but the precise mechanisms leading to glucose intolerance are not understood.
We studied in vitro effects of glucose, insulin, D,Lisoproterenol and L-thyroxine, on glycogen synthase and phosphorylase activities in polymorphonuclear leukocytes. The levels of these compounds are thought to change in hyperthyroidism. Glucose and insulin are reported to increase the glycogen synthase activity ratio in several animal tissues (4, 8 -10, 19 -21) . On the other hand, only a few experiments using human tissues have been reported. Insulin was reported to have no effect on the glycogen synthase activity ratio in human polymorphonuclear leukocytes (6) . Our data show that neither insulin nor glucose had any effect on the glycogen synthase activity ratio; however, when polymorphonuclear leukocytes were incubated with both of these compounds simultaneously, the enzyme activity ratio increased. These results indicate that in human polymorphonuclear leukocytes glucose must be present in order for insulin to increase the glycogen synthase activity ratio.
Insulin had no effect on glycogen phosphorylase activity in rat tissue cells (10, 19) ; however, Hartmann et al. reported that insulin decreased the basal and the ghicagon-activated glycogen phosphorylase activity ratio in rat hepatocyte cultures (22) . In human skeletal muscle neither insulin nor glucose changed glycogen phosphorylase activity (23) . In human polymorphonuclear leukocytes, glucose was reported to decrease the glycogen phosphorylase activity ratio (7) and this is in accordance with our results. But there is no report concerning the effect of insulin on glycogen phosphorylase activity in human polymorphonuclear leukocytes. In our experiments insulin had no effect on glycogen phosphorylase activity. Insulininsensitive glycogen synthase and phosphorylase activities in human polymorphonuclear leukocytes may explain the findings of Esmann er al. that insulin had no effect on the glycogen content of normal human polymorphonuclear leukocytes (12) .
Little is known about the effect of thyroid hormone on the control of glycogen metabolism in human polymorphonuclear leukocytes. To assess the effect of hyperthyroxinaemia on the glycogen synthase and glycogen phosphorylase activity ratios, we incubated polymorphonuclear leukocytes in vitro with L-thyroxine. A decrease of the glycogen synthase and an increase of the glycogen phosphorylase activity ratios were observed. It is suggested that an excess of L-thyroxine alters these enzyme activities in polymorphonuclear leukocytes.
Epinephrine and D,L-isoproterenol were reported to decrease the glycogen synthase activity ratio (4, 9, 11, 19, 20) and to increase the glycogen phosphorylase activity ratio (19, 24) in animal tissues. Juki et al. (7) reported that Z),L-isoproterenol did not change the glycogen synthase activity ratio but increased the glycogen phosphorylase activity ratio in human polymorphonuclear leukocytes. In our experiments D,Lisoproterenol decreased the glycogen synthase activity ratio and increased the glycogen phosphorylase activity ratio. These other authors reported a basal glycogen synthase activity ratio which was very much lower than our values, and they probably could not detect the apparent changes in glycogen synthase activity without evaluating the phosphorylation of this enzyme.
Next we examined the effect of D,L-isoproterenol and L-thyroxine on the glycogen synthase activity ratio stimulated by glucose plus insulin. Both D,L-isoproterenol and L-thyroxine diminished the glycogen synthase activity ratio which should have been enhanced by glucose plus insulin. Lawrence et al. (9) reported that in rat adipocytes insulin prevented D,L-isoproterenol from reducing the glycogen synthase activity ratio. This blocking action means that £>,L-isoproterenol blocked the ability of insulin to increase the glycogen synthase activity ratio. Our results show that, in human polymorphonuclear leukocytes, not only AL-isoproterenol but also L-thyroxine can decrease the glycogen synthase activity ratio, which is known to be increased by simultaneous incubation with glucose and insulin. We also examined the effect of Z),L-isoproterenol and L-thyroxine on the glycogen phosphorylase activity ratio suppressed by glucose. Both reagents increased the glycogen phosphorylase activity ratio which should have been decreased by glucose.
In conclusion, suppression of glycogen synthase and enhancement of glycogen phosphorylase activities by thyroid hormone and a ß-agonist impair the glycogen metabolism in human polymorphonuclear leukocytes. Although the present study shows the acute effects of thyroid hormone and a ß-agonist, if similar alterations of these enzyme activities are observed in other human tissues, they may have some relations to glucose intolerance among hyperthyroid patients. The study of glycogen metabolism in polymorphonuclear leukocytes appears to be a useful method for elucidating the impaired glucose tolerance in· hyperthyroidism.
